Table 1.

Derivation of Mac-1+Gr-1+splenocytes on D+7 after transplantation

Graft composition without G-CSFGraft composition with G-CSF
HSCs, n = 10HSC + CMP/GMP, n = 5HSCs, n = 7HSC + CMP/GMP, n = 6
Total splenocytes 111.1 ± 12.9 181.5 ± 12.9* 63.4 ± 7.5 300.8 ± 40.0*, 
Total CD45+splenocytes 82.7 ± 14.0 105.0 ± 26.2 43.1 ± 7.5 142.0 ± 20.6*, 
Total Mac-1+Gr-1+ 13.3 (16%) 29.8 (28%)* 3.7 (8.6%) 29.5 (21%)*, 
Derivation     
 Donor HSCs 11.6 ± 4.2 4.7 ± 1.2 2.5 ± 0.7 6.4 ± 1.4 
 Donor CMP/GMP  — 20.1 ± 4.9  — 14.9 ± 1.8 
 Host 1.6 ± 0.3 5.0 ± 1.6 1.2 ± 0.5 8.2 ± 5.5 
Graft composition without G-CSFGraft composition with G-CSF
HSCs, n = 10HSC + CMP/GMP, n = 5HSCs, n = 7HSC + CMP/GMP, n = 6
Total splenocytes 111.1 ± 12.9 181.5 ± 12.9* 63.4 ± 7.5 300.8 ± 40.0*, 
Total CD45+splenocytes 82.7 ± 14.0 105.0 ± 26.2 43.1 ± 7.5 142.0 ± 20.6*, 
Total Mac-1+Gr-1+ 13.3 (16%) 29.8 (28%)* 3.7 (8.6%) 29.5 (21%)*, 
Derivation     
 Donor HSCs 11.6 ± 4.2 4.7 ± 1.2 2.5 ± 0.7 6.4 ± 1.4 
 Donor CMP/GMP  — 20.1 ± 4.9  — 14.9 ± 1.8 
 Host 1.6 ± 0.3 5.0 ± 1.6 1.2 ± 0.5 8.2 ± 5.5 

Data are expressed as mean cell counts ± SEM (×104). Values in parentheses indicate the percentage of the CD45+ population that was Mac-1+Gr-1+.

*

Significantly different from HSCs without G-CSF (P < .05).

Significantly different from HSCs with G-CSF (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal